首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1524244

醫用一氧化二氮市場- 按類型（液體一氧化二氮、氣態一氧化二氮）、應用（麻醉和止痛、冷凍手術、手術吹氣）、最終用途（醫院、家庭護理場所） - 全球預測（ 2024 - 2032）

Medical Nitrous Oxide Market - By Type (Liquid Nitrous Oxide, Gaseous Nitrous Oxide), Application (Anesthesia and Pain Relief, Cryosurgery, Surgical Insufflation), End-use (Hospitals, Home Care Settings) - Global Forecast (2024 - 2032)

出版日期: 2024年04月24日 | 出版商:

Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在緊急醫療服務需求的推動下，2024年至2032年全球醫用一氧化二氮市場的複合年成長率將超過7.4%。一氧化二氮透過提供有效的疼痛緩解和鎮靜作用，在緊急醫療服務中發揮至關重要的作用，特別是在門診環境中。其起效快、作用可逆，使其成為緊急情況下治療急性疼痛和焦慮的首選。隨著醫療機構努力提高患者護理水平和效率，對一氧化二氮的需求持續成長。這一趨勢得到了其經過驗證的安全性和易於管理的支持，使其成為急診醫學的資產。對一氧化二氮的日益依賴凸顯了其在確保傳統醫院環境之外及時有效的醫療干預方面的重要性。

舉個例子，2024 年 7 月，Pinnacle Industries 推出了一款半高級型號 AD-Gen 救護車，旨在加強全國範圍內的緊急醫療運輸。儘管財政限制限制了車隊升級和技術進步，但此次發布強調了其目標是改善印度高品質緊急醫療服務的可近性。

整個醫用一氧化二氮產業根據類型、應用、最終用途和地區進行細分。

由於其在麻醉和疼痛管理方面的效率，到 2032 年，液體一氧化二氮細分市場將佔據大量醫用一氧化二氮市場。與氣態一氧化二氮相比，液態一氧化二氮具有更容易儲存、處理和精確劑量管理等優點。這使其成為精確麻醉至關重要的醫療環境中的首選。此外，醫用氣體輸送系統的進步提高了液態一氧化二氮的安全性和有效性，促進了其在全球外科手術和醫療中的應用。

由於其作為低溫劑的有效性，到 2032 年，冷凍外科領域在醫用一氧化二氮市場上將實現令人印象深刻的複合年成長率。一氧化二氮能夠達到極低的溫度 -88.48°C，使其適合冷凍和破壞異常組織生長，例如疣、皮贅和某些類型的皮膚癌。與傳統手術方法相比，這種非侵入性方法最大限度地減少了對周圍健康組織的損害，並為患者提供了更快的恢復時間。隨著冷凍手術因其功效和最小副作用而獲得認可，全球醫療實踐中對一氧化二氮作為低溫劑的需求持續成長。

由於嚴格的醫療法規強調病人安全和有效的麻醉管理，歐洲醫用一氧化二氮市場將在 2024 年至 2032 年呈現強勁的複合年成長率。歐洲醫療機構擴大採用先進的醫療技術和工藝，促進了一氧化二氮在外科手術和疼痛管理中的使用。此外，不斷增加的醫療基礎設施投資和擴大醫療保健覆蓋範圍有助於提高利用一氧化二氮進行醫療的機會。這些發展反映出人們對高效可靠的麻醉解決方案的日益青睞，從而增加了對醫用一氧化二氮的需求。

產業生態系統分析
產業影響力
- 成長動力
- 增加外科手術和牙科手術
- 慢性病盛行率上升
- 各種醫學專業擴大採用一氧化二氮
- 老年人口不斷增加
- 產業陷阱與挑戰
- 替代方案的可用性
- 濫用一氧化二氮相關的潛在風險
成長潛力分析
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按類型，2021 - 2032

主要趨勢
液體一氧化二氮
氣態一氧化二氮

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
麻醉和緩解疼痛
冷凍手術
手術吹氣

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
醫院
家庭護理設置
學術及研究機構

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Air Liquide
Calix, Inc.
Chengdu Taiyo Industrial Gases Co., Ltd.
Ellenbarrie Industrial Gases Ltd.
Linde Plc
Mitsubishi Chemical Group Corporation
Norco Inc.
NEXAIR
Oxygen & Argon Works Ltd.
Steelman Gases Pvt. Ltd.
SOL S.p.A.
The Southern Gas Limited

簡介目錄

Product Code: 9196

Global Medical Nitrous Oxide Market will exhibit over 7.4% CAGR from 2024 to 2032, propelled by demand in emergency medical services. Nitrous oxide plays a crucial role in emergency medical services by providing effective pain relief and sedation, particularly in ambulatory settings. Its quick onset and reversible effects make it a preferred option for managing acute pain and anxiety in emergencies. As healthcare facilities strive to enhance patient care and efficiency, the demand for nitrous oxide continues to rise. This trend is supported by its proven safety profile and ease of administration, making it an asset in emergency medicine. The increasing reliance on nitrous oxide underscores its significance in ensuring prompt and effective medical interventions outside traditional hospital settings.

Quoting an instance, in July 2024, Pinnacle Industries launched a semi-premium variant, the AD-Gen Ambulance, aimed at enhancing emergency medical transportation nationwide. This launch emphasizes its goal to improve accessibility to high-quality emergency medical services in India despite financial constraints limiting fleet upgrades and technological advancements.

The overall medical nitrous oxide industry is segmented based on type, application, end-use, and region.

The liquid nitrous oxide segment will capture a substantial medical nitrous oxide market share by 2032 due to its efficiency in anesthesia and pain management. Liquid nitrous oxide offers advantages such as easier storage, handling, and precise dosage administration compared to gaseous forms. This makes it a preferred choice in medical settings where accurate delivery of anesthesia is crucial. Additionally, advancements in medical gas delivery systems have enhanced the safety and efficacy of liquid nitrous oxide, boosting its adoption in surgical procedures and medical treatments worldwide.

The cryosurgery segment will register an impressive CAGR in the medical nitrous oxide market through 2032, owing to its effectiveness as a cryogenic agent. Nitrous oxides ability to reach very low temperatures -88.48°C makes it suitable for freezing and destroying abnormal tissue growths, such as warts, skin tags, and certain types of skin cancer. This non-invasive approach minimizes damage to surrounding healthy tissue and offers patients a quicker recovery time compared to traditional surgical methods. As cryosurgery gains recognition for its efficacy and minimal side effects, the demand for nitrous oxide as a cryogenic agent continues to grow in medical practices globally.

Europe medical nitrous oxide market will demonstrate a robust CAGR from 2024 to 2032 because of strict healthcare regulations emphasizing patient safety and effective anesthesia management. The increasing adoption of advanced medical technologies and techniques across European healthcare facilities has bolstered the use of nitrous oxide in surgical procedures and pain management. Moreover, growing investments in healthcare infrastructure and expanding healthcare coverage contribute to greater accessibility to medical treatments utilizing nitrous oxide. These developments reflect a growing preference for efficient and reliable anesthesia solutions, increasing the demand for medical nitrous oxide.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.2 Increasing surgical procedures and dental procedures
- 3.2.3 Rising prevalence of chronic diseases
- 3.2.4 Growing adoption of nitrous oxide across various medical specialties
- 3.2.5 Rising geriatric population
- 3.2.6 Industry Pitfalls & Challenges
- 3.2.7 Availability of alternatives
- 3.2.8 Potential risks associated with nitrous oxide misuse
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Liquid nitrous oxide
5.3 Gaseous nitrous oxide

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Anesthesia and pain relief
6.3 Cryosurgery
6.4 Surgical insufflation

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Home care settings
7.4 Academic and research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East And Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa